Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipients.
Lueck C, Tzalavras A, Wohlfarth P, Meedt E, Kiehl M, Turki AT, Hoeper MM, Eder M, Cserna J, Buchtele N, Wolff D, Schellongowski P, Beutel G, Liebregts T. Lueck C, et al. Among authors: cserna j. Bone Marrow Transplant. 2023 Mar;58(3):303-310. doi: 10.1038/s41409-022-01875-4. Epub 2022 Dec 10. Bone Marrow Transplant. 2023. PMID: 36496524 Free PMC article.
Emergency Department Utilization Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Longitudinal Analysis of 557 Patients.
Cserna J, Baumann CK, Lobmeyr E, Grafeneder J, Ettl F, Eibensteiner F, Rabitsch W, Mitterbauer M, Knaus HA, Wohlfarth P. Cserna J, et al. Transplant Cell Ther. 2023 May;29(5):321.e1-321.e9. doi: 10.1016/j.jtct.2023.02.018. Epub 2023 Feb 24. Transplant Cell Ther. 2023. PMID: 36842484 Free article.
Cytokine Release Syndrome during Antithymocyte Globulin/Anti-T Lymphocyte Globulin Serotherapy for Graft-versus-Host Disease Prophylaxis before Allogeneic Hematopoietic Stem Cell Transplantation: Incidence and Early Clinical Impact According to American Society of Transplantation and Cellular Therapy Grading Criteria.
Knaus HA, Rottner T, Baumann CK, Cserna J, Mitterbauer M, Schulenburg A, Rabitsch W, Wohlfarth P. Knaus HA, et al. Among authors: cserna j. Transplant Cell Ther. 2022 May;28(5):260.e1-260.e9. doi: 10.1016/j.jtct.2022.02.016. Epub 2022 Feb 22. Transplant Cell Ther. 2022. PMID: 35217212 Free article.